The store will not work correctly when cookies are disabled.
N-[3-(piperidin-4-yl)-5-(trifluoromethyl)phenyl]guanidine
ID: ALA4476817
PubChem CID: 134817550
Max Phase: Preclinical
Molecular Formula: C13H17F3N4
Molecular Weight: 286.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)Nc1cc(C2CCNCC2)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C13H17F3N4/c14-13(15,16)10-5-9(8-1-3-19-4-2-8)6-11(7-10)20-12(17)18/h5-8,19H,1-4H2,(H4,17,18,20)
Standard InChI Key: SVJLJEMEWHBCNB-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
39.6200 -5.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6188 -6.0611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3269 -6.4700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0365 -6.0606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0337 -5.2379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3251 -4.8327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9108 -6.4691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2034 -6.0600 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.9102 -7.2863 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.1975 -6.8718 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
41.7449 -6.4681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4520 -6.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1603 -6.4659 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4507 -5.2412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.3211 -4.0211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0294 -3.6117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0289 -2.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3218 -2.3877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.6135 -2.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6123 -3.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
7 9 1 0
7 10 1 0
4 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
6 15 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.30 | Molecular Weight (Monoisotopic): 286.1405 | AlogP: 2.48 | #Rotatable Bonds: 2 |
Polar Surface Area: 73.93 | Molecular Species: BASE | HBA: 2 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.36 | CX LogP: 1.93 | CX LogD: -2.85 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.50 | Np Likeness Score: -0.70 |
References
1. Tautermann CS, Binder F, Büttner FH, Eickmeier C, Fiegen D, Gross U, Grundl MA, Heilker R, Hobson S, Hoerer S, Luippold A, Mack V, Montel F, Peters S, Bhattacharya S, Vaidehi N, Schnapp G, Thamm S, Zeeb M.. (2019) Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule., 62 (1): [PMID:30207464] [10.1021/acs.jmedchem.8b00857] |